Skip to content
DataLookout
Menu

University of Texas Southwestern Medical Center clinical trial pipeline

Get alerts when University of Texas Southwestern Medical Center's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

20 trials changed in the last 30 days: 1 stopped, 10 with notable changes, 9 with minor changes only.

  1. Notable: IMPACT-MACS · Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion Phase changed: Not applicable → Phase 4 University of Texas Southwestern Medical CenterPhase 4 NCT07361874
  2. Minor: Obesity in the Aged Trial completed University of Texas Southwestern Medical CenterNot applicable NCT05028309
  3. Notable: Non-Invasive Testing to Evaluate Wound Healing in Diabetes Suspended trial terminated University of Texas Southwestern Medical CenterNot specified NCT04232631
  4. Notable: Cladribine Tablets After Treatment With Natalizumab (CLADRINA) Primary completion pushed from Aug 30, 2026 to May 30, 2027 University of Texas Southwestern Medical CenterPhase 4 NCT04178005
  5. Minor: TEST · Transference of Established Simulated Skills (TEST) Trial Trial completed University of Texas Southwestern Medical CenterNot specified NCT06572033
  6. Notable: Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk · Type 2 Diabetes Primary completion pushed from Sep 15, 2026 to May 15, 2027 University of Texas Southwestern Medical CenterNot applicable NCT06593314
  7. Minor: Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure Primary completion pushed from Aug 1, 2028 to Sep 1, 2028 University of Texas Southwestern Medical CenterPhase 3 NCT07018297
  8. Notable: RESOLVE-CKD · REducing Systemic Inflammation With LOw-dose Colchicine to ImproVE Cardiovascular Calcification in Chronic Kidney Disease: A Pilot Randomized Open-Label Trial Primary and study completion dates pushed to May 1, 2029 University of Texas Southwestern Medical CenterPhase 2 NCT07654231
  9. Minor: VITAS · Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors Enrollment closed, study ongoing University of Texas Southwestern Medical CenterPhase 1/2 NCT04796012
  10. Notable: Cerebellar Transcranial Direct Current Stimulation (tDCS) · Autism Spectrum Disorder: Raynor Cerebellum Project Primary and study completion pushed from Jun 30, 2026 to Dec 30, 2027 University of Texas Southwestern Medical CenterNot applicable NCT05691283
  11. Minor: SF · Targeting Social Function in Anxiety and Eating Disorders Enrollment closed, study ongoing University of Texas Southwestern Medical CenterNot applicable NCT06198023
  12. Minor: Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia Trial completed University of Texas Southwestern Medical CenterNot specified NCT04951700
  13. Notable: HIV/HBV/HCV Triple Screening in Primary Care Primary and study completion pushed from Jun 2027 to Dec 31, 2027 University of Texas Southwestern Medical CenterNot applicable NCT07031219
  14. Notable: Diuretic Tuner Clinical Decision Support Primary and study completion pushed from Aug 2026 to Aug 2028 University of Texas Southwestern Medical CenterNot applicable NCT04759274
  15. Minor: TRI-MR · Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder Trial status changed: Enrolling by Invitation → Active, Not Recruiting University of Texas Southwestern Medical CenterPhase 2 NCT07693608
  16. Minor: KMD · Ketamine for Methamphetamine Use Disorder Trial completed University of Texas Southwestern Medical CenterPhase 2 NCT06496750
  17. Notable: T-STEM · Tirzepatide for Methamphetamine Use Disorder Recruitment opened University of Texas Southwestern Medical CenterPhase 2 NCT07825857
  18. Stopped: Pre-operative Tumor Treating Fields · Resectable Lung Cancer Withdrawn before enrolling University of Texas Southwestern Medical CenterNot applicable NCT06552000
  19. Notable: Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC) Primary completion pushed from Sep 1, 2026 to Sep 1, 2027 University of Texas Southwestern Medical CenterPhase 2 NCT05931393
  20. Minor: Skin Wetting in Burn Survivors Trial completed University of Texas Southwestern Medical CenterNot applicable NCT06529757
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-12 NCT07930299 Neuromodulation of Executive Control for Substance Use Disorders Not Yet Recruiting
2026-11-12 NCT07934329 CCS Transitions to Adult Care Not Yet Recruiting
2026-10-21 NCT07886853 Pragmatic Interventions to Advance Cancer Survivor Outcomes Not Yet Recruiting
2026-10-21 NCT07887737 Deep Brain Stimulation Guided by Brain Mapping to Treat Cognitive Impairment Not Yet Recruiting

Active trials by phase

Early Phase 1
10
Phase 1
14
Phase 1/2
12
Phase 2
33
Phase 2/3
2
Phase 3
6
Phase 4
11
Not charted: 150 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 50

Get alerts when University of Texas Southwestern Medical Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free